177 related articles for article (PubMed ID: 38601813)
1. Coexistence of Eosinophilic Granulomatosis With Polyangiitis and Allergic Bronchopulmonary Aspergillosis: A Fascinating Relationship.
Marra AM; Curci P; Franco G; Pittalis G; Tugnoli E; Cavasin D; Cristiano A; Bini F
Cureus; 2024 Apr; 16(4):e57917. PubMed ID: 38601813
[TBL] [Abstract][Full Text] [Related]
2. [Eosinophilic granulomatosis with polyangiitis (EGPA) and allergic bronchopulmonary mycosis (ABPM)].
Taniguchi M; Fukutomi Y
Nihon Rinsho; 2016 Oct; 74(10):1721-1728. PubMed ID: 30551287
[TBL] [Abstract][Full Text] [Related]
3. A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.
Terashima T; Shinozaki T; Iwami E; Nakajima T; Matsuzaki T
BMC Pulm Med; 2018 Mar; 18(1):53. PubMed ID: 29587693
[TBL] [Abstract][Full Text] [Related]
4. Chronic pulmonary aspergillosis may cause eosinophilic granulomatosis with polyangiitis via allergic bronchopulmonary aspergillosis.
Harada M; Imokawa S; Miwa S; Nihashi F; Aono Y; Amano Y; Uto T; Sato J; Suda T
Oxf Med Case Reports; 2019 Feb; 2019(2):omy126. PubMed ID: 30800324
[TBL] [Abstract][Full Text] [Related]
5. Eosinophilic Granulomatosis with Polyangiitis preceding allergic bronchopulmonary aspergillosis.
Lee W; Teo FS; Santosa A; Teng GG
Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):228-31. PubMed ID: 26549342
[TBL] [Abstract][Full Text] [Related]
6. Severe asthma concomitant with allergic bronchopulmonary aspergillosis (ABPA) and non-steroid exacerbated respiratory disease (N-ERD) successfully treated with mepolizumab: A case report.
Çakmak ME
Tuberk Toraks; 2022 Jun; 70(2):215-219. PubMed ID: 35785889
[TBL] [Abstract][Full Text] [Related]
7. Mepolizumab as a glucocorticoid-sparing agent in eosinophilic granulomatosis with polyangiitis (EGPA): is a lower dose sufficient?
Vergles M; Matković Z; Lalić K; Trkanjec JT; Tudorić N
J Asthma; 2021 Dec; 58(12):1675-1679. PubMed ID: 32962455
[TBL] [Abstract][Full Text] [Related]
8. Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
Frątczak A; Polak K; Miziołek B; Bergler-Czop B
Acta Dermatovenerol Croat; 2022 Sep; 30(2):116-118. PubMed ID: 36254546
[TBL] [Abstract][Full Text] [Related]
9. Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases.
Tolebeyan A; Mohammadi O; Vaezi Z; Amini A
Cureus; 2020 Aug; 12(8):e9684. PubMed ID: 32923277
[TBL] [Abstract][Full Text] [Related]
10. Mepolizumab as the first targeted treatment for eosinophilic granulomatosis with polyangiitis: a review of current evidence and potential place in therapy.
Faverio P; Bonaiti G; Bini F; Vaghi A; Pesci A
Ther Clin Risk Manag; 2018; 14():2385-2396. PubMed ID: 30573961
[TBL] [Abstract][Full Text] [Related]
11. Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab.
Matsumoto N; Shigekusa T; Matsuo A; Tsubouchi H; Yanagi S; Nakazato M
Respirol Case Rep; 2019 Oct; 7(7):e00465. PubMed ID: 31346471
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.
Nolasco S; Portacci A; Campisi R; Buonamico E; Pelaia C; Benfante A; Triggiani M; Spadaro G; Caiaffa MF; Scioscia G; Detoraki A; Valenti G; Papia F; Tomasello A; Crimi N; Scichilone N; Pelaia G; Carpagnano GE; Crimi C
Front Immunol; 2023; 14():1204444. PubMed ID: 37457743
[TBL] [Abstract][Full Text] [Related]
13. Allergic Bronchopulmonary Aspergillosis.
Agarwal R; Muthu V; Sehgal IS; Dhooria S; Prasad KT; Aggarwal AN
Clin Chest Med; 2022 Mar; 43(1):99-125. PubMed ID: 35236565
[TBL] [Abstract][Full Text] [Related]
14. Allergic bronchopulmonary aspergillosis with marked peripheral blood eosinophilia and pulmonary eosinophilia: A case report.
Zhang XX; Zhou R; Liu C; Yang J; Pan ZH; Wu CC; Li QY
World J Clin Cases; 2023 Apr; 11(11):2457-2463. PubMed ID: 37123325
[TBL] [Abstract][Full Text] [Related]
15. New-onset of eosinophilic granulomatosis with polyangiitis without eosinophilia and eosinophilic infiltration under benralizumab treatment: A case report.
Yonezawa H; Ohmura SI; Ohkubo Y; Otsuki Y; Miyamoto T
Mod Rheumatol Case Rep; 2023 Dec; 8(1):145-149. PubMed ID: 37243733
[TBL] [Abstract][Full Text] [Related]
16. Real-life evidence of low-dose mepolizumab efficacy in EGPA: a case series.
Detoraki A; Tremante E; Poto R; Morelli E; Quaremba G; Granata F; Romano A; Mormile I; Rossi FW; de Paulis A; Spadaro G
Respir Res; 2021 Jun; 22(1):185. PubMed ID: 34162391
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Mepolizumab in Patients with Eosinophilic Granulomatosis with Polyangiitis.
Pradhan RR; Nepal G; Mandal S
Pulm Med; 2019; 2019():4376380. PubMed ID: 30941214
[TBL] [Abstract][Full Text] [Related]
18. Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan.
Yamane T; Hashiramoto A
Arthritis Res Ther; 2023 Jun; 25(1):110. PubMed ID: 37365612
[TBL] [Abstract][Full Text] [Related]
19. Combined Allergic Bronchopulmonary Aspergillosis and Eosinophilic Granulomatosis with Polyangiitis: Three Cases and a Review of the Literature.
Ishiguro T; Takayanagi N; Takaku Y; Kagiyama N; Kurashima K; Sugita Y
Intern Med; 2016; 55(7):793-7. PubMed ID: 27041167
[TBL] [Abstract][Full Text] [Related]
20. Allergic bronchopulmonary aspergillosis.
Agarwal R; Sehgal IS; Dhooria S; Muthu V; Prasad KT; Bal A; Aggarwal AN; Chakrabarti A
Indian J Med Res; 2020 Jun; 151(6):529-549. PubMed ID: 32719226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
